Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.5 HKD | +5.71% | +7.68% | -21.44% |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Apr. 22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.44% | 1.04B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+55.32% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-1.20% | 8.18B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- WHO Grants Emergency-Use Approval to CanSino’s COVID-19 Vaccine